IMAX Just Proved the Leverage Thesis — Then Refused to Predict the Sequel
A record 69% EBITDA margin, a quiet 70mm capacity unlock, and a company that won't guide 2027 despite its best quarter ever
IMAX · Earnings Call · 2026-11-05
The Proof Quarter Arrives
For years IMAX management has sold investors on "the power of the platform" — a promise that operating leverage would one day reveal itself when box office got big enough. In Q3 2026 it arrived in one print: revenue of $175M (+64%), adjusted EBITDA of $121M on a 69% margin versus 48.6% a year earlier, adjusted EPS of $2.21, and global box office of $712M — a figure Rich Gelfond described as “nearly double our previous best” — Richard Gelfond, Chief Executive Officer · 2026-11-05, on a record 7% share of the worldwide box office from just 0.8% of screens.
The mechanism is not mysterious and Natasha Fernandes has been describing it for quarters. “When we exceed $250 million of global box office in a quarter, incrementality can flow through at a margin of approximately 85%” — Natasha Fernandes, Chief Financial Officer · 2026-11-05 — and she added that on individual titles above roughly $100M, flow-through can run higher still. That is a business with fixed remastering and marketing costs and near-zero marginal cost per additional territory, and this was the quarter the fixed-cost base got swallowed whole. Free cash flow of $100M for the nine months, at 50.3% conversion from adjusted EBITDA, is the part that matters for valuation.
Gelfond used his closing remarks to settle the argument directly, and it is worth reading in full:
I must have been asked and Natasha 10,000 times to find the holes in our financial model when the leverage came together and how we would deliver or not. I have got to say, just look at this quarter, and you have got a blueprint for a fantastic model and a terrific business going forward.
That is the sound of a demand for IMAX thesis being confirmed rather than asserted. The talking point is no longer a talking point.
The 70mm Reversal Is the Real News
Buried in the Q&A is a genuine strategic turn that got almost no billing. In July, Eric Handler asked whether IMAX could double its 70mm film projector footprint, and Gelfond poured cold water on it: “It's like a Rolls-Royce. The economics are very difficult to meet and only certain people can afford a Rolls-Royce” — Richard L. Gelfond, Chief Executive Officer · 2026-07-23, adding that “you just can't say, why don't you build hundreds of them because there aren't hundreds of places where it would work.” — Richard L. Gelfond, Chief Executive Officer · 2026-07-23
Three months later, the same analyst asked again and got a different answer. “Someone realized that we have between 10 and 15 3D film theaters... we're in the process of figuring out how to split those 3D film projectors into two projectors” — Richard Gelfond, Chief Executive Officer · 2026-11-05, Gelfond said, targeting 10 to 15 new IMAX 70mm film locations. This is not a small thing: the 41 existing film sites delivered $92M, or 13% of quarterly box office, at a structurally higher take rate. Finding a second tranche of the scarcest asset in premium cinema — without new manufacturing — is the single most under-appreciated line in the transcript.
The Silence, and a Slower Cadence
The contrast worth flagging is what did not happen. After a record year, management declined to frame 2027. “We are going to give guidance sometime early next year... I understand people's, I do not mean to be pejorative, but impatience. They want to know it yesterday.” — Richard Gelfond, Chief Executive Officer · 2026-11-05 The stated reasons are real — carryover of Dune Part Three and Avengers, a strong Chinese New Year with Wandering Earth 3, and an admittedly unfilled slate — but a company sitting on its best quarter ever choosing not to anchor the next one is a tell about how thin visibility still is beyond 2026.
Meanwhile installs did the opposite of accelerating. IMAX put in 32 systems versus 38 a year prior, and while the 160–175 full-year range is intact, the quarter was described as a "breather" because exhibitors would not close auditoriums during The Odyssey's run. Eric Handler asked in July whether the backlog could be pulled forward; he asked again this quarter and got a version of the same answer — permits and work crews, not ambition, set the pace. The offset is signings: 105 year-to-date, 65% at new locations, 71 in rest-of-world versus 39 for all of 2025, with 150 more in negotiation.
New Dials, and the Ones That Went Quiet
Three genuinely new revenue concepts surfaced this quarter. First, merchandising: sold-out popcorn buckets, Godzilla apparel, a full Dune product line, and studio partners now asking to co-develop merch for 2027 releases. Second, pricing — Gelfond finally named names: “There's a theater chain in Las Vegas called Brenden Theatres... and he charged $50 for every seat for The Odyssey, and he was virtually sold out” — Richard Gelfond, Chief Executive Officer · 2026-11-05, feeding the dynamic pricing argument that has been building since the February call. Third, licensing: a Meta VR certification and an autonomous-vehicle entertainment system, both structured to carry payments to IMAX with partner-funded R&D.
Then there is Cliff Booth — the Tarantino-scripted, Fincher-directed, Brad Pitt Netflix title for which IMAX is the sole theatrical home over Thanksgiving. Gelfond was openly irritated that some exhibitors balked at the Netflix window: “it is a win-win... I do not understand why anybody would not play it” — Richard Gelfond, Chief Executive Officer · 2026-11-05. This is a live test of the Netflix theatrical model first struck for Narnia, and the exhibitor friction is a real risk to the arrangement.
What disappeared is equally telling. Alternative content and sports — both pitched hard in 2025 and again in February 2026 with the Apple F1 deal and World Cup talk — barely register now. Capacity utilization, a 2025 buzzphrase, is gone too, replaced by the more flattering market-share metric. Alternative content is a filler business; IMAX has stopped pretending otherwise.
The Tape and the Stale Ledger
IMAX is up 19% over the last 90 days, but sits 14.6% below its September 29 all-time high of $56.33. This report lands into a pullback after a parabolic run, not into strength — and the fundamentals on file are a quarter behind reality, reflecting the 10-Q filed July 23 for the period ended June 30. Those show gross margin of 61.2%, up 2.7pp, on $103M of revenue. The Q3 figures above will re-base every one of these series.
Valuation is the interesting wrinkle. At roughly 5.3x revenue and 22x free cash flow less stock comp, the multiple has actually fallen 37% year over year — earnings are outrunning the share price. And the $36.7M valuation allowance release was ring-fenced by Fernandes: excluding it, adjusted net income of $91.3M and EPS of $1.58 were still full-year records.
The honest read: this was the quarter that validated a decade of IMAX awakening rhetoric, and management's refusal to quantify 2027 — while running a deliberate cost discipline line and a slower install cadence — is the price of that credibility. The platform is proven. The next chapter is being written quarterly, not annually.